Hegyi, B., Csikó, K. G., Balatoni, T., Fröhlich, G., Bőcs, K., Tóth, E., . . . Ladányi, A. (2024). Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients. Biomolecules (2218-273X), 14(12), 1609. https://doi.org/10.3390/biom14121609
Chicago Style (17th ed.) CitationHegyi, Barbara, et al. "Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients." Biomolecules (2218-273X) 14, no. 12 (2024): 1609. https://doi.org/10.3390/biom14121609.
MLA (9th ed.) CitationHegyi, Barbara, et al. "Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients." Biomolecules (2218-273X), vol. 14, no. 12, 2024, p. 1609, https://doi.org/10.3390/biom14121609.